Cefiwok-CV combines Cefixime 200 mg and Clavulanate Potassium 125 mg, creating a powerful antibiotic formulation used to treat a wide range of bacterial infections. Cefixime is a broad-spectrum cephalosporin that effectively targets various gram-positive and gram-negative bacteria, while Clavulanate Potassium enhances its efficacy by inhibiting beta-lactamase enzymes produced by resistant bacteria. This combination is particularly effective for respiratory tract infections, urinary tract infections, and certain skin infections, making Cefiwok-CV a reliable choice for comprehensive infection management.
Reviews
There are no reviews yet.